Sean Kendall

Sean Kendall has made 69 investments in companies such as: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics, Cero Therapeutics, Encoded Therapeutics, Locanabio, Faraday Pharmaceuticals, AgBiome, Metacrine, One BioMed, Hangzhou Just Biotherapeutics (Just China), Biopalette, Karuna Therapeutics, Homology Medicines, Sana Biotechnology, Nebula Genomics, Nohla Therapeutics, Hua Medicine, Vividion Therapeutics, ImmuneID, Epirium Bio, Singleron Biotechnologies, Ultivue, Verve Therapeutics, Geneception, Aspen Neuroscience, Bit Bio, Erasca, Codiak Biosciences, Semma Therapeutics, UNITY Biotechnology, AnchorDx, Encodia, Sesh, EGenesis, Transcenta, Omniome, Maze Therapeutics, Resilience, ROME Therapeutics, Walden Biosciences, Sonoma BioTherapeutics, Vir Biotechnology, BlackThorn Therapeutics, Glympse Bio, Scholar Rock, Dewpoint Therapeutics, Volastra Therapeutics, Agrivida, ImmusanT, EQRx, Vizgen, Magnolia NeuroSciences, HiberCell, Gossamer Bio, Insitro, LunaPBC, Autobahn Therapeutics, CStone Pharmaceuticals, Nutcracker Therapeutics, Mindstrong, Boundless Bio, LunaDNA, Brii Biosciences, Beam Therapeutics, Voxel8, Cytrellis Biosystems, Qihan Biotech.

The free version of Angel Match provides limited data for Sean Kendall. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.

A short brief about investor: